MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales and maturities
of marketable...
$1,300K
Net proceeds from
at-the-market sales
$1,234K
Proceeds from exercise of
stock options
$14K
Net cash provided by
investing activities
$1,300K
Net cash provided by
financing activities
$1,248K
Net increase
(decrease) in cash and cash...
-$10,815K
Canceled cashflow
$2,548K
Accounts payable
$1,059K
Stock-based compensation
$344K
Depreciation and
amortization
$283K
Noncash operating lease
expense
$154K
Net cash used in
operating activities
-$13,363K
Canceled cashflow
$1,840K
Net loss
-$9,796K
Accrued liabilities and
other liabilities
$4,735K
Prepaid expenses and
other assets
$308K
Lease liabilities
-$269K
Amortization of premiums and
discounts on marketable...
$59K
Other long-term
liabilities
-$36K
Back
Back
Cash Flow
source: myfinsight.com
NextCure, Inc. (NXTC)
NextCure, Inc. (NXTC)